BioAscent Discovery Limited has announced an agreement with Pivot Park Screening Centre (PPSC, Oss, The Netherlands), under which it is managing PPSC’s entire screening collection of over 300,000 compounds.
This new library consolidates BioAscent’s position as one of the largest and most efficient outsourced sample management providers in the World.
By accessing BioAscent’s infrastructure and technologies, PPSC is able to optimise the use of its compounds and preserve their quality, in addition to saving time during the screening process.
BioAscent’s Newhouse facility offers scalable and highly secure infrastructure, capable of storing over 4 million compounds in solid and liquid formats, and numerous tube and microplate types, from ambient to -20 °C.
As well as ongoing sample management, BioAscent has extensive reformatting capabilities and has already transferred 233,000 aliquots of DMSO stock solutions from microplates into individual tubes.
This additional tube format will enable PPSC to cherry pick ‘hit’ compounds following primary ultra-high throughput screening and to confirm and validate their activity on the target. PPSC will also be able to undertake follow up assays faster than before.
